AMS Asia is a next-generation HealthTech company transforming the science of aging into a precision-driven, preventative discipline
We specialize in proprietary regenerative therapies, integrative diagnostics, and personalized longevity protocols designed not only to increase lifespan but also to enhance overall health, vitality, and performance. At the core of our approach is the seamless fusion of cutting-edge biotechnology with a deeply personalized, outcome-focused philosophy, one grounded in clinical integrity, scientific rigor, and an unwavering commitment to exceptional care.
Operating through a network of innovation labs and clinical partners across Europe, Southeast Asia, and Japan, AMS Asia combines global expertise with local insight to deliver world-class solutions in stem cell therapy, exosome technology, bioidentical hormone optimization, and age management medicine.
Beyond patient care, we empower the medical ecosystem through research collaboration, physician training, and technology transfer, building a global alliance for the future of proactive health. Our team brings deep experience in laboratory development and international certification processes, having successfully supported the planning, construction, and regulatory alignment of state-of-the-art biotech labs across Asia and Europe. From GMP-compliant cell processing facilities to ISO-certified diagnostic platforms, AMS Asia provides the technical and operational expertise needed to establish cutting-edge, accredited laboratories tailored for regenerative and personalized medicine.
Trusted by patients and partners in over 12 countries including Vietnam, Japan, the EU, Ukraine, USA, Canada, Cambodia, Indonesia, Malaysia, India, Singapore, Thailand, and Mongolia, we are setting a new global benchmark in regenerative care. At AMS Asia, we don't just treat conditions, we engineer vitality.
A Strategic Partner of the Global Age Management Alliance (GAMA)
AMS Asia is proud to operate as a strategic member of the Global Age Management Alliance (GAMA) which is an international network of leading institutions, clinics, and innovators advancing the science and practice of age management medicine. Through GAMA, we collaborate with top-tier partners across the globe to define standards, exchange expertise, and accelerate access to life-changing regenerative therapies.
GAMA serves as a hub for medical education, clinical research, and biotechnological innovation, supporting physicians and clinics in delivering next-gen solutions rooted in evidence and best practices. As part of this alliance, AMS Asia gains early access to emerging protocols, global insights, and an evolving knowledge base dedicated to reshaping the future of human health.
Together with GAMA, we are building a connected ecosystem of longevity leaders committed to delivering sustainable, personalized, and globally impactful care.
